Patents by Inventor Liora Almany

Liora Almany has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
    Patent number: 9700600
    Abstract: A method of treating a disorder characterized by tissue damage is provided. The method comprising providing to a subject in need-thereof a composition which comprises a synthetic polymer attached to denatured fibrinogen or a therapeutic portion of the fibrinogen, the composition being formulated for releasing the therapeutic portion of the fibrinogen in a pharmacokinetically regulated manner, thereby treating the disorder characterized by tissue damage or malformation.
    Type: Grant
    Filed: August 31, 2015
    Date of Patent: July 11, 2017
    Assignee: Regentis Biomaterials Ltd.
    Inventors: Dror Seliktar, Liora Almany
  • PEGYLATED FIBRINOGEN PRECURSOR MOLECULE
    Publication number: 20160375174
    Abstract: The present invention relates to biodegradable scaffolds composed of a naturally-occurring protein backbone cross-linked by a synthetic polymer. Specifically, the present invention provides PEGylated-fibrinogen scaffold and methods of generating and using same for treating disorders requiring tissue regeneration.
    Type: Application
    Filed: September 8, 2016
    Publication date: December 29, 2016
    Applicant: Regentis Biomaterials Ltd.
    Inventors: Dror SELIKTAR, Liora ALMANY
  • PEGylated fibrinogen precursor molecule
    Patent number: 9474830
    Abstract: The present invention relates to biodegradable scaffolds composed of a naturally-occurring protein backbone cross-linked by a synthetic polymer. Specifically, the present invention provides PEGylated-fibrinogen scaffold and methods of generating and using same for treating disorders requiring tissue regeneration.
    Type: Grant
    Filed: October 13, 2014
    Date of Patent: October 25, 2016
    Assignee: Regentis Biomaterials Ltd.
    Inventors: Dror Seliktar, Liora Almany
  • MATRIX COMPOSED OF A NATURALLY-OCCURRING PROTEIN BACKBONE CROSS LINKED BY A SYNTHETIC POLYMER AND METHODS OF GENERATING AND USING SAME
    Publication number: 20150359856
    Abstract: A method of treating a disorder characterized by tissue damage is provided. The method comprising providing to a subject in need-thereof a composition which comprises a synthetic polymer attached to denatured fibrinogen or a therapeutic portion of the fibrinogen, the composition being formulated for releasing the therapeutic portion of the fibrinogen in a pharmacokinetically regulated manner, thereby treating the disorder characterized by tissue damage or malformation.
    Type: Application
    Filed: August 31, 2015
    Publication date: December 17, 2015
    Applicant: REGENTIS BIOMATERIALS LTD.
    Inventors: Dror SELIKTAR, Liora ALMANY
  • Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
    Patent number: 9120872
    Abstract: A method of treating a disorder characterized by tissue damage is provided. The method comprising providing to a subject in need-thereof a composition which comprises a synthetic polymer attached to denatured fibrinogen or a therapeutic portion of the fibrinogen, the composition being formulated for releasing the therapeutic portion of the fibrinogen in a pharmacokinetically regulated manner, thereby treating the disorder characterized by tissue damage or malformation.
    Type: Grant
    Filed: October 27, 2010
    Date of Patent: September 1, 2015
    Assignee: Regentis Biomaterials Ltd.
    Inventors: Dror Seliktar, Liora Almany
  • PEGYLATED FIBRINOGEN PRECURSOR MOLECULE
    Publication number: 20150030580
    Abstract: The present invention relates to biodegradable scaffolds composed of a naturally-occurring protein backbone cross-linked by a synthetic polymer. Specifically, the present invention provides PEGylated-fibrinogen scaffold and methods of generating and using same for treating disorders requiring tissue regeneration.
    Type: Application
    Filed: October 13, 2014
    Publication date: January 29, 2015
    Inventors: DROR SELIKTAR, LIORA ALMANY
  • Pegylated fibrinogen precursor molecule
    Patent number: 8858925
    Abstract: The present invention relates to biodegradable scaffolds composed of a naturally-occurring protein backbone cross-linked by a synthetic polymer. Specifically, the present invention provides PEGylated-fibrinogen scaffold and methods of generating and using same for treating disorders requiring tissue regeneration.
    Type: Grant
    Filed: July 13, 2011
    Date of Patent: October 14, 2014
    Assignee: Regentis Biomaterials Ltd.
    Inventors: Dror Seliktar, Liora Almany
  • MATRIX COMPOSED OF A NATURALLY-OCCURRING PROTEIN BACKBONE CROSS LINKED BY A SYNTHETIC POLYMER AND METHODS OF GENERATING AND USING SAME
    Publication number: 20120020911
    Abstract: The present invention relates to biodegradable scaffolds composed of a naturally-occurring protein backbone cross-linked by a synthetic polymer. Specifically, the present invention provides PEGylated-fibrinogen scaffold and methods of generating and using same for treating disorders requiring tissue regeneration.
    Type: Application
    Filed: July 13, 2011
    Publication date: January 26, 2012
    Applicant: Regentis Biomaterials Ltd.
    Inventors: Dror Seliktar, Liora Almany
  • Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
    Patent number: 8007774
    Abstract: The present invention relates to biodegradable scaffolds composed of a naturally-occurring protein backbone cross-linked by a synthetic polymer. Specifically, the present invention provides PEGylated-fibrinogen scaffold and methods of generating and using same for treating disorders requiring tissue regeneration.
    Type: Grant
    Filed: June 22, 2006
    Date of Patent: August 30, 2011
    Assignee: Regentis Biomaterials Ltd.
    Inventors: Dror Seliktar, Liora Almany
  • MATRIX COMPOSED OF A NATURALLY-OCCURRING PROTEIN BACKBONE CROSS LINKED BY A SYNTHETIC POLYMER AND METHODS OF GENERATING AND USING SAME
    Publication number: 20110038828
    Abstract: A method of treating a disorder characterized by tissue damage is provided. The method comprising providing to a subject in need-thereof a composition which comprises a synthetic polymer attached to denatured fibrinogen or a therapeutic portion of the fibrinogen, the composition being formulated for releasing the therapeutic portion of the fibrinogen in a pharmacokinetically regulated manner, thereby treating the disorder characterized by tissue damage or malformation.
    Type: Application
    Filed: October 27, 2010
    Publication date: February 17, 2011
    Applicant: REGENTIS BIOMATERIALS LTD.
    Inventors: DROR SELIKTAR, LIORA ALMANY
  • Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
    Patent number: 7842667
    Abstract: A method of treating a disorder characterized by tissue damage is provided. The method comprising providing to a subject in need-thereof a composition which comprises a synthetic polymer attached to denatured fibrinogen or a therapeutic portion of the fibrinogen, the composition being formulated for releasing the therapeutic portion of the fibrinogen in a pharmacokinetically regulated manner, thereby treating the disorder characterized by tissue damage or malformation.
    Type: Grant
    Filed: June 22, 2006
    Date of Patent: November 30, 2010
    Assignee: Regentis Biomaterials Ltd.
    Inventors: Dror Seliktar, Liora Almany
  • Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
    Publication number: 20060233855
    Abstract: A method of treating a disorder characterized by tissue damage is provided. The method comprising providing to a subject in need-thereof a composition which comprises a synthetic polymer attached to denatured fibrinogen or a therapeutic portion of the fibrinogen, the composition being formulated for releasing the therapeutic portion of the fibrinogen in a pharmacokinetically regulated manner, thereby treating the disorder characterized by tissue damage or malformation.
    Type: Application
    Filed: June 22, 2006
    Publication date: October 19, 2006
    Inventors: Dror Seliktar, Liora Almany
  • Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
    Publication number: 20060233854
    Abstract: The present invention relates to biodegradable scaffolds composed of a naturally-occurring protein backbone cross-linked by a synthetic polymer. Specifically, the present invention provides PEGylated-fibrinogen scaffold and methods of generating and using same for treating disorders requiring tissue regeneration.
    Type: Application
    Filed: June 22, 2006
    Publication date: October 19, 2006
    Inventors: Dror Seliktar, Liora Almany